Emergent BioSolutions to pause vaccine manufacturing at Baltimore facility

A federal inspection of the plant remains ongoing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.